In the preliminary investigation using RNAseq data of gastric cancer patients’ tissue, we found that the combined evaluation of RTKs, such as MET and FGFR2 amplification, could identify the specificity of gastric tumor cells when compared to normal tissue. This evidence concerns the gene MET and gastric cancer.